Judge Kacsmaryk's preliminary decision came after a group of anti-abortion health professionals launched a case challenging the safety.

His 7 April ruling was made just minutes before a decision from a judge in Washington state ordered the FDA to make no change to the drug's availability and preserved access to mifepristone in 17 US states. คาสิโนที่ดีที่สุด